| History and Archaeology | 2021-2025 | 51 | IN 3 | 98.87 |
| Mathematics and Statistics | 2021-2025 | 477 | IN 20 | 95.54 |
| Ophthalmology | Lifetime | 177 | IN 6 | 98.97 |
| History of Science, Technology and Medicine | Lifetime | 563 | IN 2 | 97.50 |
| Dermatology | Lifetime | 517 | IN 3 | 95.94 |
| Otolaryngology | Lifetime | 336 | IN 5 | 94.61 |
| Health Informatics | Lifetime | 89 | IN 6 | 87.83 |
| History of Science, Technology and Medicine | 2021-2025 | 3 | IN 1 | 99.64 |
| Ophthalmology | 2021-2025 | 34 | IN 3 | 99.09 |
| Public, Environmental and Occupational Health | 2021-2025 | 258 | IN 5 | 97.76 |
| Surgery | 2021-2025 | 380 | IN 5 | 97.21 |
| Statistics, Probability and Uncertainty | 2021-2025 | 98 | IN 1 | 94.76 |
| Health Informatics | 2021-2025 | 104 | IN 6 | 92.79 |
| Pathology and Forensic Medicine | 2021-2025 | 253 | IN 2 | 92.32 |
| Dermatology | 2021-2025 | 208 | IN 2 | 92.07 |
| Information Systems | 2021-2025 | 875 | IN 41 | 91.95 |
| Otolaryngology | 2021-2025 | 156 | IN 6 | 86.59 |
| Language and Linguistics | 2021-2025 | 401 | IN 1 | 80.63 |
| Radiology, Nuclear Medicine and Imaging | 2021-2025 | 831 | IN 24 | 79.70 |
| Educational Technology and Online Learning | 2021-2025 | 425 | IN 3 | 77.69 |
| Rheumatology | 2021-2025 | 482 | IN 3 | 73.14 |
| Genetics | 2021-2025 | 816 | IN 13 | 72.53 |
| Physical Therapy, Sports Therapy and Rehabilitation | 2021-2025 | 204 | IN 2 | 67.89 |
| Nasolacrimal Duct Obstruction Treatments | Lifetime | 7 | IN 1 | 98.89 |
| Sinusitis and nasal conditions | Lifetime | 111 | IN 4 | 98.61 |
| Head and Neck Surgical Oncology | Lifetime | 312 | IN 7 | 98.51 |
| Cancer and Skin Lesions | Lifetime | 211 | IN 2 | 98.08 |
| Salivary Gland Tumors Diagnosis and Treatment | Lifetime | 273 | IN 3 | 98.19 |
| Ocular Surface and Contact Lens | Lifetime | 282 | IN 12 | 98.13 |
| Oral and Maxillofacial Pathology | Lifetime | 502 | IN 9 | 97.51 |
| Congenital Ear and Nasal Anomalies | Lifetime | 67 | IN 2 | 96.24 |
| Ophthalmology and Eye Disorders | Lifetime | 415 | IN 7 | 96.58 |
| Ocular Infections and Treatments | Lifetime | 265 | IN 19 | 97.03 |
| Ocular Oncology and Treatments | Lifetime | 324 | IN 11 | 95.24 |
| Soft tissue tumor case studies | Lifetime | 454 | IN 7 | 94.36 |
| IgG4-Related and Inflammatory Diseases | Lifetime | 230 | IN 1 | 93.08 |
| Facial Trauma and Fracture Management | Lifetime | 774 | IN 14 | 91.94 |
| Biomedical Research and Pathophysiology | Lifetime | 464 | IN 3 | 91.05 |
| Ocular Disorders and Treatments | Lifetime | 468 | IN 14 | 87.00 |
| scientometrics and bibliometrics research | Lifetime | 546 | IN 9 | 88.01 |
| History of Medicine Studies | Lifetime | 356 | IN 3 | 84.56 |
| Sympathectomy and Hyperhidrosis Treatments | Lifetime | 814 | IN 10 | 82.08 |
| Academic Writing and Publishing | Lifetime | 180 | IN 5 | 77.27 |
| Academic Publishing and Open Access | Lifetime | 317 | IN 5 | 72.31 |
| Salivary Gland Tumors Diagnosis and Treatment | 2021-2025 | 15 | IN 1 | 98.58 |
| Nasolacrimal Duct Obstruction Treatments | 2021-2025 | 1 | IN 1 | 99.31 |
| Ocular Surface and Contact Lens | 2021-2025 | 34 | IN 4 | 98.49 |
| Ophthalmology and Eye Disorders | 2021-2025 | 21 | IN 1 | 97.84 |
| Head and Neck Surgical Oncology | 2021-2025 | 54 | IN 1 | 97.38 |
| Cancer and Skin Lesions | 2021-2025 | 31 | IN 1 | 96.15 |
| Sinusitis and nasal conditions | 2021-2025 | 55 | IN 1 | 96.91 |
| scientometrics and bibliometrics research | 2021-2025 | 28 | IN 2 | 94.52 |
| Ocular Infections and Treatments | 2021-2025 | 94 | IN 27 | 92.01 |
| Glaucoma and retinal disorders | 2021-2025 | 841 | IN 35 | 91.81 |
| Soft tissue tumor case studies | 2021-2025 | 119 | IN 5 | 83.66 |
| IgG4-Related and Inflammatory Diseases | 2021-2025 | 118 | IN 1 | 82.22 |
| Congenital Ear and Nasal Anomalies | 2021-2025 | 39 | IN 1 | 75.11 |
| Oral and Maxillofacial Pathology | 2021-2025 | 814 | IN 84 | 80.17 |
| Biomedical Research and Pathophysiology | 2021-2025 | 127 | IN 4 | 77.52 |
| Meta-analysis and systematic reviews | 2021-2025 | 541 | IN 5 | 79.50 |
| Language Acquisition and Education | 2021-2025 | 867 | IN 1 | 46.97 |
| Porphyrin Metabolism and Disorders | 2021-2025 | 929 | IN 38 | 19.63 |